HomeQLGN • NASDAQ
add
Qualigen Therapeutics Inc
Previous close
$3.93
Day range
$3.17 - $4.00
Year range
$2.85 - $17.10
Market cap
5.38M USD
Avg Volume
1.62M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.19M | -63.57% |
Net income | -855.82K | 65.07% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -971.92K | 57.24% |
Effective tax rate | -0.65% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.17M | 192.33% |
Total assets | 4.69M | 130.49% |
Total liabilities | 2.01M | -51.47% |
Total equity | 2.68M | — |
Shares outstanding | 1.64M | — |
Price to book | -0.95 | — |
Return on assets | -69.51% | — |
Return on capital | -246.66% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -855.82K | 65.07% |
Cash from operations | -2.27M | 59.98% |
Cash from investing | -1.01M | -527.95% |
Cash from financing | 4.06M | 3,793.98% |
Net change in cash | 786.46K | 114.18% |
Free cash flow | -3.16M | -7.10% |
About
Founded
1996
Headquarters
Website
Employees
4
